ORBITA Trials Are Not Justification to Promote a PCI-First Strategy in Nonacute Myocardial Ischemic Syndromes.
William E BodenRaffaele De CaterinaPublished in: Circulation. Cardiovascular quality and outcomes (2024)
Keyphrases
- percutaneous coronary intervention
- acute myocardial infarction
- left ventricular
- coronary artery disease
- acute coronary syndrome
- antiplatelet therapy
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- ischemia reperfusion injury
- atrial fibrillation
- coronary artery bypass grafting
- heart failure
- oxidative stress